Biocon Ltd Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030: Hi, everyone hopes Everything is great at your place so today we are going to do a detailed analysis about one of the Indian biopharmaceutical companies that is founded in Bangalore, which is Biocon Ltd. try to include every aspect which is necessary to know before investing in this biopharmaceutical Company which listed as a Syngene International Ltd. in Share Market.

Biocon Ltd. is an Indian Pharmaceutical Company founded by Kiran Mazumdar Shaw. Biocon Ltd. manufactures generic Active Pharmaceutical Ingredients (API) which the Company sold in about 120 Countries across the globe with their license which includes the United States and the whole of Europe. Biocon Ltd. was Founded in 1978 with Rs.10000 as initial Capitals.

In the year 2001 Biocon becomes the first Indian Company to be approved by USFDA for the manufacture of life savings Drugs that is Lovastation and it was patent by their name itself. In the year 2003 Biocon becomes the first Company in World to develop human insulin on an expression System. In the year 2011 Biocon launches INSUPen, a convenient and affordable reusable insulin delivery device that help humankind too much in the near past years. 

Also Read: PNB Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Biocon has a number of Subsidiaries which include Syngene International Ltd. which was established in 1993 and they offer their services in research organizations and try to offer pharmaceutical and biotechnology majors solutions in molecular biology for early-stage drug discovery and development. In the year 2003 Biocon established Biocon Biopharmaceuticals Pvt. Ltd. (BBPL)as a partner with the Cuban Institute CIMAB to develop affordable cancer vaccines.

Biocon’s Formulates for the Indian market Includes metabolic, oncology, immunotherapy, and nephrology products. Some of BIOCON’s key brands in India include INSUGEN, BASALOG, BLISTO, TACROGRAF, and KRABEVA. Biocon and Syngene together employ about 9200 personnel. Biocon offers 36 brands of products across the four therapeutic divisions of diabetology, nephrology, oncology, and cardiology.

Also Read: SBI Cards And Payment Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

There is a number of ratios which help us to know whether the Company is in a good state or not. So ROE% for Biocon for the last 1 year is about 3.68% and ROE% for Biocon for the last 3 years is about 5.64% and ROE% for Biocon for the last 5 years is around 5.78% and ROCE% of Biocon for the last 1 year is around 4.65% and ROCE% for last 3 year is about 6.72% and ROCE% of Biocon for last 5 year is around 6.6% which is really impressive in itself.

Biocon Ltd. shares were divided into numbers of sectors but a large part of the ratio of their shares are in the hand of their Promoters they occupied around 60.64% of the Company shares. Public occupied around 15.93% of the Company shares and the remaining percentage of their shares were occupied by FLL and Dll. So in this section we try to predict three possible share price targets for the shares of this company first share price target for the share of Biocon Ltd. is about Rs.481.80 and the second share price target for the shares of this company is around Rs.565 and the third and the final share price target for the year 2022 is around Rs.658.

Also Read: LTI Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Biocon trading in channel pattern in a monthly time frame and they try to follow Elliott wave theory and they try to take support on 0.618 Fibonacci level after analyzing all these things we can predict its short term trend is negative and in a downtrend and its long term trend is also positive and in an uptrend. So here we try to predict two share price targets for the share of this company the first share price target for the year 2023 is around Rs.768 and the second share price target for the shares of Biocon Ltd. is about Rs.846.

Also Read: COLPAL Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

When we go through the data provided to us we can see some downfall by some terms that are Profit Growth is very bad for the shares of Biocon Ltd. is about -36.38% and sales growth are also lying in the negative direction and it is about -7.13% but because of their Market Cap which is about Rs.43857.92Cr. it will recover soon and here we try to predict two share price targets for the shares of Biocon first is around Rs.944 and the second share price target for the share of Biocon is about Rs.1049.

Also Read: Havells India Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Biocon Ltd. made a handsome amount of profit from last 5 years which help them to emerge as one of the renowned names in the Company and its net profit after paying all the taxes is increasing per year but last year because of the Nation Wide Lockdown they make little less amount of profit from earlier years and here we try to predict two shares price target for the shares of Biocon Ltd the first target for the shares of this company is around 1123 and second share price target for the shares of this company at the end of the year 2025 is about Rs.1221.

Also Read: Dabur India Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Till the end of this decade, Biocon Will emerge as best in their field because of the development and manufacturer of life-saving drugs which include drugs for a diabetes patient, Kidney Patients, Oncologic Patients, Neurologic Patients and they also try to develop some vaccines for the breast cancer people because of all of that Biocon Ltd. can sustain their top Place in the biopharmaceutical sector in India and here we try to predict two share price target for the shares of Biocon Ltd. which they can attain at the end of this decade first is around Rs.2589 and second share price target for the shares of Biocon Ltd. is about Rs.3432.

Also Read: DMART Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

A friend here we try to give you an expert view on the shares of Biocon Ltd. according to the terms called Ownership, Valuation, Efficiency, and financials. Here when we talk about ownership strength is slightly missing the benchmark but it will acquire their secure position in near future and when we talk about the efficiency of the company it seems highly inefficient in the case of asset management. 

So If we talk about the financials of this company they could improve upon its asset employment and they really need to improve this to increase their capital and if talk about the valuation of this company is at a premium valuation at this point and they also need to improve on this aspect too.

Also Read: Bajaj Finance Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Here we try to tell you some strength which helps you to know more about the Company Shares and data which we try to give you there is get it from Ticker.finology.in and if find any miss correct data regarding the shares Biocon Ltd. we will not going to be responsible for it.

1. Biocon Ltd. has a high promoter holding of shares which is about 60.64% of its total share which tells us how promoters strongly run this Company.

2. Biocon Ltd. has a strong degree of operating Leverage and its average Leverage we find it around 3.04.

3. Biocon Ltd. has a healthy Liquidity position market with a current ratio of 3.94 which is really better than compared other pharmaceutical companies in India.

4. Biocon Ltd. has Strong brand equity, Strong Management team with a cost advantage.

5. Bicon Ltd. has a strong research team that always tends to innovate something new and useful for mankind.

Also Read: Bajaj Finserv Ltd Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

Here we try to tell you some limitations and weaknesses of the Biocon Ltd. which is really essential to know before investing in the shares of this Company and data which we try to give you there is get it from Ticker.finology.in and if you find any miss correct information regarding the shares of Biocon Ltd. we will not be responsible for it.

1. Biocon Ltd. has shown a poor profit growth of 5.56% for the past 3 years which they really need to improve in Upcoming Years.

2. Biocon Ltd. has shown poor revenue growth which lies in the negative direction of -5.70% for the last 3 years.

3. Presently Biocon Ltd. traded at a high PE of 195.10 which will become very risky in upcoming years to come if they were not able to improve their sales growth and profit growth.

4. Biocon Ltd. has a limited presence in the European markets which is none of the biggest markets for any Pharmaceutical Company and Biocon Ltd. will try to improve their market visibility.

Also Read: Asian Paints Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030

In this artical, We have done a detailed analysis about Biocon Ltd Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030 and tried to include every aspect in our article which is really essential to know before investing in any specific company shares which include company strength, limitations, share price target for the company shares, try to tell every relatable news, research and updates regarding this share of Biocon Ltd. which can become one of the safest options for you to invest. 

Also Read: Axis Bank Share Price Target/Prediction/Forecast 2022, 2023, 2024, 2025, And 2030